Translocation-driven sarcomas, e.g. ES, DSRCT, and SYNS, exhibited highly recurrent copy number changes, indicating that there may be additional relevant genetic events beyond the driver translocations (Fig. 3B). This evidence concerns the gene STS and sarcoma.